251 related articles for article (PubMed ID: 34530900)
1. Targeting the methyltransferase SETD8 impairs tumor cell survival and overcomes drug resistance independently of p53 status in multiple myeloma.
Herviou L; Ovejero S; Izard F; Karmous-Gadacha O; Gourzones C; Bellanger C; De Smedt E; Ma A; Vincent L; Cartron G; Jin J; De Bruyne E; Grimaud C; Julien E; Moreaux J
Clin Epigenetics; 2021 Sep; 13(1):174. PubMed ID: 34530900
[TBL] [Abstract][Full Text] [Related]
2. Progress in the Development of Lysine Methyltransferase SETD8 Inhibitors.
Milite C; Feoli A; Viviano M; Rescigno D; Mai A; Castellano S; Sbardella G
ChemMedChem; 2016 Aug; 11(16):1680-5. PubMed ID: 27411844
[TBL] [Abstract][Full Text] [Related]
3. The Histone Methyltransferase SETD8 Regulates the Expression of Tumor Suppressor Genes via H4K20 Methylation and the p53 Signaling Pathway in Endometrial Cancer Cells.
Kukita A; Sone K; Kaneko S; Kawakami E; Oki S; Kojima M; Wada M; Toyohara Y; Takahashi Y; Inoue F; Tanimoto S; Taguchi A; Fukuda T; Miyamoto Y; Tanikawa M; Mori-Uchino M; Tsuruga T; Iriyama T; Matsumoto Y; Nagasaka K; Wada-Hiraike O; Oda K; Hamamoto R; Osuga Y
Cancers (Basel); 2022 Oct; 14(21):. PubMed ID: 36358786
[TBL] [Abstract][Full Text] [Related]
4. Epigenetic Modifier SETD8 as a Therapeutic Target for High-Grade Serous Ovarian Cancer.
Wada M; Kukita A; Sone K; Hamamoto R; Kaneko S; Komatsu M; Takahashi Y; Inoue F; Kojima M; Honjoh H; Taguchi A; Kashiyama T; Miyamoto Y; Tanikawa M; Tsuruga T; Mori-Uchino M; Wada-Hiraike O; Osuga Y; Fujii T
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33339442
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic siRNA and Chemical Screens Identify SETD8 Inhibition as a Therapeutic Strategy for p53 Activation in High-Risk Neuroblastoma.
Veschi V; Liu Z; Voss TC; Ozbun L; Gryder B; Yan C; Hu Y; Ma A; Jin J; Mazur SJ; Lam N; Souza BK; Giannini G; Hager GL; Arrowsmith CH; Khan J; Appella E; Thiele CJ
Cancer Cell; 2017 Jan; 31(1):50-63. PubMed ID: 28073004
[TBL] [Abstract][Full Text] [Related]
6. The SETD8/PR-Set7 Methyltransferase Functions as a Barrier to Prevent Senescence-Associated Metabolic Remodeling.
Tanaka H; Takebayashi SI; Sakamoto A; Igata T; Nakatsu Y; Saitoh N; Hino S; Nakao M
Cell Rep; 2017 Feb; 18(9):2148-2161. PubMed ID: 28249161
[TBL] [Abstract][Full Text] [Related]
7. The histone lysine methyltransferase SETD8 regulates angiogenesis through HES-1 in human umbilical vein endothelial cells.
Choi DK; Kim YK; Park SW; Lee H; Lee S; Kim SA; Kim SJ; Lee J; Kim W; Min SH; Yu JH
Sci Rep; 2020 Jul; 10(1):12089. PubMed ID: 32694555
[TBL] [Abstract][Full Text] [Related]
8. Structure-activity relationship studies of SETD8 inhibitors.
Ma A; Yu W; Xiong Y; Butler KV; Brown PJ; Jin J
Medchemcomm; 2014 Dec; 5(12):1892-1898. PubMed ID: 25554733
[TBL] [Abstract][Full Text] [Related]
9. The PPARγ-SETD8 axis constitutes an epigenetic, p53-independent checkpoint on p21-mediated cellular senescence.
Shih CT; Chang YF; Chen YT; Ma CP; Chen HW; Yang CC; Lu JC; Tsai YS; Chen HC; Tan BC
Aging Cell; 2017 Aug; 16(4):797-813. PubMed ID: 28514051
[TBL] [Abstract][Full Text] [Related]
10. Roles for the methyltransferase SETD8 in DNA damage repair.
Xu L; Zhang L; Sun J; Hu X; Kalvakolanu DV; Ren H; Guo B
Clin Epigenetics; 2022 Mar; 14(1):34. PubMed ID: 35246238
[TBL] [Abstract][Full Text] [Related]
11. The emerging role of lysine methyltransferase SETD8 in human diseases.
Milite C; Feoli A; Viviano M; Rescigno D; Cianciulli A; Balzano AL; Mai A; Castellano S; Sbardella G
Clin Epigenetics; 2016; 8():102. PubMed ID: 27688818
[TBL] [Abstract][Full Text] [Related]
12. SETD8 stabilized by USP17 epigenetically activates SREBP1 pathway to drive lipogenesis and oncogenesis of ccRCC.
Li X; Liu Z; Xia C; Yan K; Fang Z; Fan Y
Cancer Lett; 2022 Feb; 527():150-163. PubMed ID: 34942305
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic Determinants of Erythropoiesis: Role of the Histone Methyltransferase SetD8 in Promoting Erythroid Cell Maturation and Survival.
DeVilbiss AW; Sanalkumar R; Hall BD; Katsumura KR; de Andrade IF; Bresnick EH
Mol Cell Biol; 2015 Jun; 35(12):2073-87. PubMed ID: 25855754
[TBL] [Abstract][Full Text] [Related]
14. Discovery of a selective, substrate-competitive inhibitor of the lysine methyltransferase SETD8.
Ma A; Yu W; Li F; Bleich RM; Herold JM; Butler KV; Norris JL; Korboukh V; Tripathy A; Janzen WP; Arrowsmith CH; Frye SV; Vedadi M; Brown PJ; Jin J
J Med Chem; 2014 Aug; 57(15):6822-33. PubMed ID: 25032507
[TBL] [Abstract][Full Text] [Related]
15. The histone methyltransferase Setd8 acts in concert with c-Myc and is required to maintain skin.
Driskell I; Oda H; Blanco S; Nascimento E; Humphreys P; Frye M
EMBO J; 2012 Feb; 31(3):616-29. PubMed ID: 22117221
[TBL] [Abstract][Full Text] [Related]
16. SETD8 potentiates constitutive ERK1/2 activation via epigenetically silencing DUSP10 expression in pancreatic cancer.
Liu M; Qin Y; Hu Q; Liu W; Ji S; Xu W; Fan G; Ye Z; Zhang Z; Xu X; Yu X; Zhuo Q
Cancer Lett; 2021 Feb; 499():265-278. PubMed ID: 33232789
[TBL] [Abstract][Full Text] [Related]
17. Histone lysine methyltransferase SETD8 promotes carcinogenesis by deregulating PCNA expression.
Takawa M; Cho HS; Hayami S; Toyokawa G; Kogure M; Yamane Y; Iwai Y; Maejima K; Ueda K; Masuda A; Dohmae N; Field HI; Tsunoda T; Kobayashi T; Akasu T; Sugiyama M; Ohnuma S; Atomi Y; Ponder BA; Nakamura Y; Hamamoto R
Cancer Res; 2012 Jul; 72(13):3217-27. PubMed ID: 22556262
[TBL] [Abstract][Full Text] [Related]
18. Small-molecule inhibitors of SETD8 with cellular activity.
Blum G; Ibáñez G; Rao X; Shum D; Radu C; Djaballah H; Rice JC; Luo M
ACS Chem Biol; 2014 Nov; 9(11):2471-8. PubMed ID: 25137013
[TBL] [Abstract][Full Text] [Related]
19. Targeted inhibition of the methyltransferase SETD8 synergizes with the Wee1 inhibitor adavosertib in restraining glioblastoma growth.
Della Monica R; Buonaiuto M; Cuomo M; Pagano C; Trio F; Costabile D; de Riso G; Cicala FS; Raia M; Franca RA; Del Basso De Caro M; Sorrentino D; Navarra G; Coppola L; Tripodi L; Pastore L; Hench J; Frank S; Schonauer C; Catapano G; Bifulco M; Chiariotti L; Visconti R
Cell Death Dis; 2023 Sep; 14(9):638. PubMed ID: 37758718
[TBL] [Abstract][Full Text] [Related]
20. The histone methyltransferase Setd8 alters the chromatin landscape and regulates the expression of key transcription factors during erythroid differentiation.
Myers JA; Couch T; Murphy Z; Malik J; Getman M; Steiner LA
Epigenetics Chromatin; 2020 Mar; 13(1):16. PubMed ID: 32178723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
